Use of fetal fibronectin in the management of preterm labour in Nunavut.
To manage suspected preterm labour in the Baffin Region of Nunavut safely and more conservatively utilizing the Fetal Fibronectin Assay. Chart Review. The trial of Fetal Fibronectin took place in the Baffin Region of Nunavut. An initial chart review of all admissions for "false labour" to Baffin Regional Hospital was performed. An analysis of the cases was done to determine when the women delivered and whether they had been Medevaced. The Fetal Fibronectin test was implemented at five sites in the Baffin Region and data on each use of the assay were collected by the laboratory at Baffin Regional Hospital. A review of the data for the first 13 months of the trial was then done. The test was used 38 times between July 2004 and September 2005. There were 31 negative results. Most of the cases with negative results were managed conservatively, with a total of 18 Medevacs avoided. There were no false negative tests. Cost savings for avoided Medevacs were in the order of $200,000. The Fetal Fibronectin Assay has proven to be a valuable adjunct in the management of suspected preterm labour in Nunavut.